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BACKGROUND: Smokers with low body mass index (BMI) may be more susceptible to lung cancer.
METHODS: We prospectively examined the association between baseline BMI and lung cancer risk in the Singapore Chinese Health
Study, a cohort of 63257 Chinese enrolled between 1993 and 1998.
RESULTS: After adjustment for smoking intensity and duration, BMI was inversely associated with risk of lung cancer among current
smokers (P for trend¼0.0004). Current smokers at different dosage of smoking with low BMI had significantly higher risk for lung
cancer than those with high BMI. Hazard ratios (95% confidence intervals) of lung cancer for heavy smokers with BMI of X28, 24–
o28, 20–o24, and o20kgm
 2 were 6.37 (2.10–19.30), 9.01 (5.04–16.10), 8.53 (6.35–11.5), and 11.12 (6.60–18.70), respectively,
as compared with nonsmokers. BMI had no modifying effects on lung cancer risk among nonsmokers and former smokers.
CONCLUSION: Smokers with lower BMI may experience an enhanced risk of lung cancer. The findings have significant public-health
implication given the increase in smoking prevalence in developing countries, where people still have relatively low BMI.
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Lung cancer has the highest incidence and mortality rates in many
countries, and cigarette smoking is estimated to account for as
high as 90% of all cases (IARC, 1986). However, there is a wide
variation in lung cancer incidence among smokers, as it has been
estimated that approximately only 16% of current smokers among
men and 10% of current smokers among women would die from
lung cancer by 75-years of age (Peto et al, 2000). The determinants
of risk include duration and intensity of smoking, exposure to
asbestos (O’Reilly et al, 2007), and radiation (Jacob et al, 2007);
other factors include uptake and metabolism of tobacco carcino-
gens (Yuan et al, 2009), variations in nicotine receptor-related
genes (Amos et al, 2008; Hung et al, 2008), inflammatory response
to the tobacco-induced lung damage (Engels et al, 2007) and DNA
repair (Hu et al, 2005).
Although certain studies (mainly in western populations) have
shown an inverse association between body mass index (BMI) and
lung cancer risk (Knekt et al, 1991; Kabat and Wynder, 1992; Kark
et al, 1995), this association is often criticised as caused by
inadequate adjustment for cigarette smoking, as both smoking
status and its intensity are strongly related to both BMI and lung
cancer incidence. In fact, this inverse association was largely
eliminated when the analysis was limited to nonsmokers (Henley
et al, 2002). Recently, a prospective study of BMI and lung cancer
mortality among 220000 Chinese men, a relatively lean population,
found that low BMI was associated with increased risk only among
current smokers (Yang et al, 2009). In this study, we prospectively
examined this subject in a cohort of 63257 middle-aged and older
Chinese men and women in Singapore, a population with a mean
BMI of 23kgm
 2. We also examined whether BMI has a modifying
effect on smoking- and nonsmoking-related lung cancer risk.
MATERIALS AND METHODS
The design of the Singapore Chinese Health Study has been
described previously (Hankin et al, 2001). Briefly, the cohort was
drawn from permanent residents or citizens of Singapore, who
resided in government-built housing estates. The age eligibility
criterion was 45–74 years and recruitment was restricted to the
two major dialect groups of Chinese in Singapore, the Hokkiens
and the Cantonese. Between April 1993 and December 1998, 63257
subjects (about 85% of eligible subjects approached) were
recruited. In this study, we excluded 1936 individuals with a
baseline history of invasive cancer (except non-melanoma skin
cancer) or superficial, papillary bladder cancer from the analysis,
leaving 61321 subjects. The study was approved by the Institu-
tional Review Boards of the National University of Singapore and
the University of Minnesota.
At the time of recruitment, an in-person interview was
conducted at the subject’s residence by a trained interviewer using
a structured questionnaire. This covered demographics, lifetime
use of tobacco (cigarettes and water-pipe), current physical
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tional exposure, medical history, and family history of cancer.
Current diet was assessed using a 165-item food frequency
questionnaire that has been validated against a series of 24-h
dietary recall interviews (Hankin et al, 2001) and selected
biomarker studies (Seow et al, 1998a,b) conducted on random
subsets of cohort participants.
The subjects were enquired for their current weight and height
by the interviewer. BMI was calculated as the current weight in
kilograms divided by height in metres squared. There were 9781
cohort participants with unknown weight, 97 with unknown
height, and 192 with both unknown weight and height. Their BMIs
were calculated using imputed weight and/or height derived from
the linear regression equation:
Weight ¼ y-intercept þ gradient height
where values for the y-intercept and gradient were obtained from
gender-specific weight-height regression lines drawn from all
cohort participants with known heights and weights. If only weight
or height was missing, the linear regression equation was used to
estimate the missing value. If both weight and height were missing,
the missing height was assigned the sex-specific median value and
missing weight value calculated from the linear regression
equation. Subjects were classified into never smoker, former
smoker, and current smoker as described previously
(Koh et al, 2005).
Deaths and incident cancers among cohort members were
identified by record linkage of the cohort with databases from the
population-based Singapore Cancer Registry and the Singapore
Registry of Births and Deaths. The nationwide cancer registry, in
place since 1968, has been shown to be comprehensive in its
ascertainment of cancers (Parkin et al, 2002). As of April 2008,
only 27 cases were lost to follow-up because of migration out of
Singapore. As of 31 December 2006, 1042 cohort participants who
were cancer-free at baseline had developed lung cancer. Of these,
912 (87.5%) were diagnosed histologically and they were
confirmed via manual review of pathology reports by a medically
trained research staff; 96 (9.2%) cases were diagnosed clinically
and 34 (3.3%) cases were identified through death certificates.
Data analysis
The subjects were classified into groups of BMIo20, 20–o24,
24–o28, and X28kgm
 2, revised categories that are more
appropriate to characterise obesity in Asian populations. For each
subject, person-years of follow-up were counted from the date of
recruitment to the date of diagnosis of lung cancer, death, or 31
December 2006, whichever occurred first. Proportional hazards
(Cox) regression methods were used to examine the associations
with BMI and other exposure factors (Cox, 1972). The strength of
the association was measured by hazard ratio (HR) and its 95%
confidence interval (CI) and P-value. All Cox’s regression models
included age at recruitment (years), gender, dialect group
(Hokkien, Cantonese), and year of recruitment. When examining
the BMI–lung cancer association, the models also included level of
education (no formal education, primary school, secondary or
higher education), number of cigarettes smoked per day (never
smoker, 1–12, 13–22, or 23þ), number of years of smoking
(never smokers, 1–19, 20–39, or 40þ), number of years since
quitting smoking (continuous smokers, o1, 1–4, 5–19, 20þ,o r
never smokers), and dietary intakes of b-cryptoxanthin
(mg1000kcal
 1), factors that were associated with lung cancer
risk in the study population (Yuan et al, 2003). Analyses were
carried out for men and women separately, as well as combined for
both sexes. As all exposure–lung cancer risk associations were
comparable between men and women, results were presented for
both sexes combined with adjustment for gender. Statistical
computing was conducted using SAS version 9.1 (SAS Institute,
Cary, NC, USA) statistical software package. All P-values quoted
are two sided.
RESULTS
As of 31 December 2006, 1042 cohort participants (717 males and
325 females) were diagnosed with lung cancer, at a mean age
(±s.d.) of 69.3 (±7.2) years for men and 69.6 (±8.4) years for
women. The mean time interval between baseline interview and
diagnosis was 10.7 years (range, from 1 month to 13.9 years).
Smoking was a strong risk predictor: compared with never
smokers, current smokers had an HR of 5.85 (95% CI¼4.99–
6.87) for lung cancer. The risk increased monotonically with
increasing number of cigarettes per day and number of years of
smoking. Among former smokers, number of years since quitting
smoking habit was associated with monotonically reduced risk of
lung cancer (Table 1).
The mean BMI (±s.d.) is 23.0 (±3.2)kgm
 2 in men and 23.2
(±3.3)kgm
 2 in women. After adjustment for smoking history
(number of cigarettes smoked per day, number of years of
smoking, and number of years since quitting smoking for former
smokers) and other potential confounders, low BMI was associated
with a statistically significant increased risk of lung cancer (P for
trend¼0.0004). We also carried out parallel analysis after
excluding subjects with imputed BMI (10070 subjects, 221 lung
cancers), the results being essentially identical with those
based on the entire cohort (Table 2). This inverse BMI-lung
cancer association was confined to current smokers. Current
smokers with BMI o20kgm
 2 had an HR of 1.91 (95% CI¼1.12–
3.25) for lung cancer compared with current smokers with
comparable smoking history but with BMI X28kgm
 2 (Table 3);
after excluding current smokers with imputed BMI (2280
Table 1 Cigarette smoking in relation to lung cancer risk, the Singapore
Chinese Health Study 1993–2006
Cigarette smoking No. of cases Rate
a HR (95% CI)
b
Smoking status
Never smokers 287 68 1.00
Former smokers 156 200 2.24 (1.81–2.78)
Current smokers 599 387 5.85 (4.99–6.87)
No. of cigarettes per day
Never smokers 287 65 1.00
1–12 193 281 4.32 (3.55–5.23)
13–22 259 390 6.61 (5.46–8.02)
23+ 147 670 9.49 7.58–11.88)
P for trend o0.0001
No. of years of smoking
Never smokers 287 68 1.00
1–19 30 109 1.52 (1.03–2.24)
20–39 213 210 3.20 (2.63–3.89)
40+ 512 442 7.11 (5.98–8.45)
P for trend o0.0001
No. of years since quitting smoking
Current smokers 599 387 1.00
o1 24 480 0.91 (0.60–1.37)
1–4 40 284 0.51 (0.37–0.71)
5–19 66 194 0.37 (0.28–0.47)
20+ 26 106 0.21 (0.14–0.31)
P for trend o0.0001
aRate per 100000 person-years adjusted for age and sex.
bHazard ratios (HRs) were
adjusted for age at baseline, sex, dialect group and year of interview; confidence
interval (CI).
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CI¼1.13–3.28).
There was no evidence that the inverse BMI–lung cancer
association was influenced significantly by the duration of follow-
up. Exclusion of lung cancer cases and person-years of observation
in the first 5 years post-enrollment did not materially alter the
inverse association between BMI and lung cancer risk. Similarly,
exclusion of subjects with pre-existing respiratory diseases
(tuberculosis, allergic rhinitis, rhinitis, sinusitis, and asthma) and
other diseases/conditions (coronary heart disease, stroke, diabetes,
peptic ulcer, partial removal of stomach, and polyps of intestines)
also did not materially change the inverse association.
We further examined the interactive effects of BMI and cigarette
smoking on risk. Among subjects with BMI X28kgm
 2, current
smokers had an HR of 3.21 (95% CI¼1.58–6.51) compared with
nonsmokers; the corresponding figures for BMI o20kgm
 2 were
7.21 (95% CI¼4.84–10.75) (Table 4). Similarly, HRs (95% CIs) for
heavy smokers (23þ cigarettes per day) relative to nonsmokers
within each category of BMI X28, 24–o28, 20–o24, and
o20kgm
 2 were 6.37 (2.10–19.30), 9.01 (5.04–16.10), 8.53 (6.35–
11.5), and 11.12 (6.60–18.70), respectively (Table 4).
DISCUSSION
Our results showed an inverse, dose–dependent association
between BMI and lung cancer risk among current smokers of
both sexes, after adjustment for duration (years of smoking)
and intensity (number of cigarettes smoked per day) of smoking.
This association remained after exclusion of subjects with
pre-existing disease or the first 5-years of follow-up data (both
person-years and lung cancer cases). There was no association
between BMI and lung cancer risk in either former or never
smokers.
Table 2 Body mass index (BMI) in relation to lung cancer risk, the Singapore Chinese Health Study 1993–2006
Whole cohort Excluding subjects with imputed BMI
Body mass index (kgm
 2) No. of cases Rate
a HR (95% CI)
b No. of cases Rate
a HR (95% CI)
b
X28 49 120 1.00 49 116 1.00
24–o28 164 111 0.91 (0.66–1.25) 164 110 0.92 (0.67–1.27)
20–o24 609 167 1.18 (0.88–1.59) 388 155 1.22 (0.91–1.65)
o20 220 218 1.34 (0.98–1.83) 220 213 1.37 (1.00–1.88)
P for trend 0.0004 0.0002
aRate per 100000 person-years adjusted for age and sex.
bHazard ratios (HRs) were adjusted for age at baseline, sex, dialect group and year of interview, level of education,
number of cigarettes smoked day, number of years of smoking, number of years since quitting smoking for former smokers, and dietary intake of b-cryptoxanthin; confidence
interval (CI).
Table 3 Body mass index (BMI) in relation to lung cancer risk by smoking status, the Singapore Chinese Health Study 1993–2006
Never smokers Former smokers Current smokers
BMI (kgm
 2) Cases Rate
a HR (95% CI)
b Cases Rate
a HR (95% CI)
c Cases Rate
a HR (95% CI)
c
X28 23 78 1.00 11 152 1.00 15 217 1.00
24–o28 50 52 0.69 (0.42–1.13) 40 217 0.98 (0.50–1.91) 74 292 1.15 (0.66–2.01)
20–o24 176 75 1.01 (0.65–1.56) 82 208 0.85 (0.45–1.60) 351 391 1.58 (0.94–2.65)
o20 38 60 0.93 (0.55–1.56) 23 202 0.85 (0.41–1.75) 159 503 1.91 (1.12–3.25)
P for trend 0.31 0.46 o0.0001
aRate per 100000 person-years adjusted for age and sex.
bHazard ratios (HRs) were adjusted for age at baseline, sex, dialect group and year of interview, level of education, and
dietary intake of b-cryptoxanthin; confidence interval (CI).
cFurther adjusted for number of cigarettes smoked day, number of years of smoking, and number of years since quitting
smoking (for former smokers only).
Table 4 Cigarette smoking in relation to lung cancer risk by levels of body mass index, the Singapore Chinese Health Study 1993–2006
X28kgm
 2 24–o28kgm
 2 20–o24kgm
 2 o20kgm
 2
Cases HR (95% CI)
a Cases HR (95% CI)
a Cases HR (95% CI)
a Cases HR (95% CI)
a
Smoking status
Never smokers 23 1.00 50 1.00 176 1.00 38 1.00
Former smokers 11 1.99 (0.88–4.52) 40 2.96 (1.84–4.76) 82 1.97 (1.48–2.62) 23 2.46 (1.40–4.32)
Current smokers 15 3.21 (1.58–6.51) 74 5.50 (3.64–8.32) 351 5.20 (4.22–6.41) 159 7.21 (4.84–10.75)
No. of cigarettes per day
b
1–12 6 2.90 (1.15–7.27) 21 3.65 (2.12–6.28) 105 3.65 (2.82–4.73) 61 6.18 (3.98–9.58)
13–22 4 2.21 (0.71–6.86) 31 5.41 (3.23–9.05) 161 6.39 (4.98–8.20) 63 7.92 (5.01–12.53)
23+ 5 6.37 (2.10–19.3) 22 9.01 (5.04–16.1) 85 8.53 (6.35–11.5) 35 11.12 (6.60–18.7)
P for trend 0.001 o0.0001 o0.0001 o0.0001
aHazard ratios (HRs) were adjusted for age at baseline, sex, dialect group and year of interview, level of education, and dietary intake of b-cryptoxanthin; confidence interval (CI).
bAmong current smokers only; all HRs were relative to never smokers.
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association was consistent across a range of smoking intensity.
Hence, for the same dose of smoking, smokers with low BMI
(o20kgm
 2) had a significantly elevated risk of lung cancer
relative to smokers with high BMI. Thus, lung cancers in people
with low BMI could be from factors associated with leanness or the
biological effect of leanness itself. It is biologically plausible that
leanness may modulate the carcinogenic effects of smoking
directly. Cross sectional and longitudinal studies have shown that
both BMI itself and the decrease in BMI inversely correlated with
the level of urinary 8-hydroxydeoxyguanosine (8-OHdG), a marker
of oxidative DNA damage in smokers, suggesting that BMI may
serve as an independent marker for host susceptibility to smoking-
related cancer (Loft et al, 1992; Mizoue et al, 2006, 2007). Smoking
may induce weight loss by increasing the metabolic rate, which
also leads to higher production of cellular-reactive species, a
carcinogenic pathway that is, therefore, enhanced among lean
smokers (Loft et al, 1992).
In a 16-year prospective study of a Chinese cohort recruited
during 1970s, the relative risk of lung cancer in male smokers was
3.8 (Chen et al, 1997) compared with those typically 20-fold
reported in western populations (Peto et al, 1994). This apparently
lower risk associated with smoking among Chinese has been
attributed to lighter dose of smoking and the relatively late age of
starting to smoke in China (Chen et al, 1997). There are disturbing
observations that the mean cigarette consumption by Chinese men
is increasing rapidly (Liu et al, 1998) and that smoking is starting
at an earlier age (Yang, 1997). Lung cancer mortality attributed to
smoking in China can therefore be expected to rapidly increase
from the current 63% (Chen et al, 1997) to the above 90% levels
noted in certain industrialised countries (Ezzati and Lopez, 2003).
Our study suggests that for the same intensity of smoking, the risk
of lung cancer may be higher among the leaner Chinese than their
western counterparts with higher BMI. Projected lung cancer
estimates based on relative risks derived from western populations
with heavier BMI may therefore seriously underestimate the true
burden among the leaner Chinese.
The strengths of our study included (1) the population-based
prospective study design with a large number of genetically
homogeneous subjects, (2) detailed information on smoking and
potential confounders including diet and other lifestyle factors,
and medical history, (3) virtually complete follow-up of deaths and
incident cancers, and (4) histological confirmation of most lung
cancers (87.5%). A potential limitation was the use of self-reported
heights and weights at baseline, but these have consistently been
shown to be reliable with relatively small mean errors (Gorber
et al, 2007). In addition, although the risk estimates were not
significantly different between the two genders, the relatively small
number of current smokers in women prevented our detecting a
significant gender difference in the relationship between BMI and
lung cancer risk among current smokers.
Given the strong impact of cigarette smoking on both BMI and
lung cancer risk, inadequate adjustment for smoking may produce
a spurious association with BMI (Kabat and Wynder, 1992;
Kanashiki et al, 2005). To adjust for smoking, we included details
of numbers of cigarettes smoked and years of smoking at baseline
interview in multivariate regression models. Studies with short
follow-up may also be confounded by preclinical weight loss or by
pre-existing disease, which may contribute to both leanness and
lung cancer risk. The exclusion of pre-existing clinical disease
or subjects with o5 years of follow-up did not materially change
our results.
Prospective studies have largely reported null associations
between BMI and lung cancer risk among never and former
smokers either among women (Kabat et al, 2008) or both genders
in various population (Henley et al, 2002; Inoue et al, 2004;
Kanashiki et al, 2005), and recently in large prospective Asian
cohorts (Jee et al, 2008; Yang et al, 2009). Our data are consistent
with these previous studies.
The finding of an inverse association between BMI and lung
cancer risk in current smokers has important implications
given the marked increase in smoking prevalence in China and
other developing countries, where people still have relatively low
body weights.
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